JPWO2020059892A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020059892A5 JPWO2020059892A5 JP2020549318A JP2020549318A JPWO2020059892A5 JP WO2020059892 A5 JPWO2020059892 A5 JP WO2020059892A5 JP 2020549318 A JP2020549318 A JP 2020549318A JP 2020549318 A JP2020549318 A JP 2020549318A JP WO2020059892 A5 JPWO2020059892 A5 JP WO2020059892A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- insulin
- positive
- rate
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 28
- 210000004027 cell Anatomy 0.000 claims 27
- 102000004877 Insulin Human genes 0.000 claims 14
- 108090001061 Insulin Proteins 0.000 claims 14
- 229940125396 insulin Drugs 0.000 claims 14
- 239000003814 drug Substances 0.000 claims 6
- 238000001727 in vivo Methods 0.000 claims 6
- 102000010792 Chromogranin A Human genes 0.000 claims 3
- 108010038447 Chromogranin A Proteins 0.000 claims 3
- 102000051325 Glucagon Human genes 0.000 claims 2
- 108060003199 Glucagon Proteins 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- 102100028096 Homeobox protein Nkx-6.2 Human genes 0.000 claims 2
- 101000578254 Homo sapiens Homeobox protein Nkx-6.1 Proteins 0.000 claims 2
- 101000578258 Homo sapiens Homeobox protein Nkx-6.2 Proteins 0.000 claims 2
- 208000013016 Hypoglycemia Diseases 0.000 claims 2
- 101150084866 MAFA gene Proteins 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 claims 2
- 229960004666 glucagon Drugs 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- 230000002218 hypoglycaemic effect Effects 0.000 claims 2
- 230000003914 insulin secretion Effects 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 210000001778 pluripotent stem cell Anatomy 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims 1
- 229940125830 FGFR1 inhibitor Drugs 0.000 claims 1
- 108010023082 activin A Proteins 0.000 claims 1
- 230000004069 differentiation Effects 0.000 claims 1
- 230000002124 endocrine Effects 0.000 claims 1
- 210000004039 endoderm cell Anatomy 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 claims 1
- 238000002513 implantation Methods 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 210000004153 islets of langerhan Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000291 postprandial effect Effects 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018175465 | 2018-09-19 | ||
| JP2018175465 | 2018-09-19 | ||
| PCT/JP2019/037725 WO2020059892A1 (ja) | 2018-09-19 | 2019-09-18 | インスリン産生細胞 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020059892A1 JPWO2020059892A1 (ja) | 2021-08-30 |
| JPWO2020059892A5 true JPWO2020059892A5 (cg-RX-API-DMAC7.html) | 2022-09-13 |
| JP7295576B2 JP7295576B2 (ja) | 2023-06-21 |
Family
ID=69887298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020549318A Active JP7295576B2 (ja) | 2018-09-19 | 2019-09-18 | インスリン産生細胞 |
Country Status (14)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019169351A1 (en) | 2018-03-02 | 2019-09-06 | Semma Therapeutics, Inc. | Methods of enhancing stem cell differentiation into beta cells |
| CN112912490B (zh) * | 2018-08-03 | 2023-12-26 | 千纸鹤治疗公司 | 细胞制造方法 |
| EP3833365A4 (en) | 2018-08-10 | 2022-05-11 | Vertex Pharmaceuticals Incorporated | Stem cell derived islet differentiation |
| JP7705448B2 (ja) | 2020-07-31 | 2025-07-09 | バーテックス ファーマシューティカルズ インコーポレイテッド | 膵内分泌細胞の分化 |
| CN116391028A (zh) * | 2020-11-20 | 2023-07-04 | 千纸鹤治疗公司 | 促熟剂 |
| TW202246489A (zh) * | 2021-02-09 | 2022-12-01 | 日商千紙鶴治療公司 | 成熟化劑 |
| JP2024542041A (ja) | 2021-11-01 | 2024-11-13 | バーテックス ファーマシューティカルズ インコーポレイテッド | 幹細胞由来の膵臓島分化 |
| IL315122A (en) * | 2022-04-25 | 2024-10-01 | Orizuru Therapeutics Inc | Maturing agent having both of alk5 inhibitory activity and cdk8/19 inhibitory activity |
| EP4596675A4 (en) | 2022-09-26 | 2026-03-11 | Univ Kyoto | PROCESS FOR THE PRODUCTION OF PANCREATIC ENDODERMAL CELLS |
| EP4753734A1 (en) * | 2023-08-02 | 2026-06-10 | Joslin Diabetes Center, Inc. | Ribosomal remodeling in diabetes |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005096873A1 (de) | 2004-04-10 | 2005-10-20 | Henkel Kommanditgesellschaft Auf Aktien | Lockenwickler |
| EP2206724A1 (en) | 2005-12-13 | 2010-07-14 | Kyoto University | Nuclear reprogramming factor |
| US8278104B2 (en) | 2005-12-13 | 2012-10-02 | Kyoto University | Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2 |
| NZ571427A (en) * | 2006-03-02 | 2012-07-27 | Viacyte Inc | Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
| US7661738B2 (en) | 2006-11-28 | 2010-02-16 | Veritainer Corporation | Radiation detection unit for mounting a radiation sensor to a container crane |
| MX348010B (es) | 2007-04-07 | 2017-05-23 | Whitehead Inst Biomedical Res | Reprogramacion de celulas somaticas. |
| JP2010528622A (ja) | 2007-05-30 | 2010-08-26 | ザ ジェネラル ホスピタル コーポレイション | 体細胞から多能性細胞を生成する方法 |
| JP2008307007A (ja) | 2007-06-15 | 2008-12-25 | Bayer Schering Pharma Ag | 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞 |
| WO2009012428A2 (en) | 2007-07-18 | 2009-01-22 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
| US9446168B2 (en) | 2010-06-07 | 2016-09-20 | Beta-O2 Technologies Ltd. | Multiple-layer immune barrier for donor cells |
| US9540630B2 (en) | 2008-09-17 | 2017-01-10 | Beta O2 Technologies Ltd. | Optimization of alginate encapsulation of islets for transplantation |
| JP5875597B2 (ja) * | 2010-12-08 | 2016-03-02 | ヴィアサイト,インコーポレイテッド | ヒト万能性幹細胞の成長を阻害する薬剤および方法 |
| US20120270890A1 (en) * | 2011-04-22 | 2012-10-25 | Cheng-Ho Chung | Methods of Pancreatic Beta Cell Regeneration |
| RU2705001C2 (ru) * | 2011-12-22 | 2019-11-01 | Янссен Байотек, Инк. | Дифференцировка эмбриональных стволовых клеток человека в одногормональные инсулинположительные клетки |
| IL321825A (en) * | 2013-02-06 | 2025-08-01 | Viacyte Inc | Cell compositions derived from dedifferentiated reprogrammed cells |
| WO2015002888A1 (en) * | 2013-07-01 | 2015-01-08 | Trustees Of Boston University | Dissolvable hydrogel compositions for wound management and methods of use |
| SG11201700874SA (en) | 2014-08-04 | 2017-03-30 | Takeda Pharmaceuticals Co | Method for proliferation of pancreatic progenitor cells |
| CN107250349A (zh) * | 2014-12-19 | 2017-10-13 | 詹森生物科技公司 | 多能干细胞的悬浮培养 |
| HK1254740A1 (zh) * | 2015-11-30 | 2019-07-26 | Kadimastem Ltd. | 分化和纯化胰腺内分泌细胞的方法 |
| MA45329A (fr) * | 2016-04-08 | 2019-02-13 | Univ California | Production de cellules bêta matures pleinement fonctionnelles à partir de progénitrices pancréatiques humaines |
| JP6863805B2 (ja) | 2017-04-14 | 2021-04-21 | グローリー株式会社 | 各台装置及び各台装置制御方法 |
| AU2019261083B2 (en) * | 2018-04-23 | 2025-01-23 | Orizuru Therapeutics, Inc. | Growth inhibitor |
-
2019
- 2019-09-18 TW TW108133603A patent/TWI862513B/zh active
- 2019-09-18 EP EP19863748.0A patent/EP3854869A4/en active Pending
- 2019-09-18 CN CN201980061019.8A patent/CN112867787B/zh active Active
- 2019-09-18 US US17/277,406 patent/US20210353686A1/en active Pending
- 2019-09-18 BR BR112021004815-4A patent/BR112021004815A2/pt unknown
- 2019-09-18 CA CA3113608A patent/CA3113608A1/en active Pending
- 2019-09-18 SG SG11202102748WA patent/SG11202102748WA/en unknown
- 2019-09-18 WO PCT/JP2019/037725 patent/WO2020059892A1/ja not_active Ceased
- 2019-09-18 KR KR1020217006143A patent/KR102892433B1/ko active Active
- 2019-09-18 MX MX2021003147A patent/MX2021003147A/es unknown
- 2019-09-18 IL IL281531A patent/IL281531B2/en unknown
- 2019-09-18 JP JP2020549318A patent/JP7295576B2/ja active Active
- 2019-09-18 AU AU2019343003A patent/AU2019343003B2/en active Active
-
2021
- 2021-03-29 CO CONC2021/0003947A patent/CO2021003947A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10927350B2 (en) | Methods for generating stem cell-derived beta cells and uses thereof | |
| US12123023B2 (en) | Methods for generating stem cell-derived β cells and methods of use thereof | |
| US20240156874A1 (en) | Methods for generating stem cell-derived beta cells and uses thereof | |
| WO2014201167A4 (en) | SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME | |
| RU2018132199A (ru) | Дифференцировка эмбриональных стволовых клеток человека в одногормональные инсулинположительные клетки | |
| AU2015372420B2 (en) | Method of inducing beta cells from urine-derived cells using small molecules | |
| Thakur et al. | Small molecule-induced pancreatic β-like cell development: mechanistic approaches and available strategies | |
| Nemati et al. | Efficiency of stem cell (SC) differentiation into insulin‐producing cells for treating diabetes: a systematic review | |
| CN107530379A (zh) | 用于治疗肥胖症和2型糖尿病(t2d)的胰腺内分泌祖细胞疗法 | |
| RU2021110684A (ru) | Инсулин-продуцирующие клетки | |
| Soria et al. | A role for the host in the roadmap to diabetes stem cell therapy | |
| Xi et al. | Stem cells therapy in diabetes mellitus | |
| Im et al. | Recent research trend in cell and drug delivery system for type 1 diabetes treatment | |
| Jun | In vivo regeneration of insulin-producing β-cells | |
| Marques et al. | A demanding path from iPSCs toward pancreatic β-and α-cells | |
| Omori et al. | 410.6: Gastrin-17 promotes survival and function and decreases inflammation of long-term cultured human islets | |
| Jin et al. | Reviewing major mechanisms of β-cell regeneration: A prospective treatment for diabetes mellitus | |
| Zhu et al. | Biomimetic hydrogels promote pseudoislet formation to improve glycemic control in diabetic mice | |
| Nadi et al. | The impact of nanofibers on stem cell differentiation to insulin-producing cells | |
| Ahsan | Use of stem cells for the Study and treatment of type 1 diabetes | |
| Wang et al. | 410.5: Prolactin modulates the differentiation of pancreatic ductal cell to islet-like cell | |
| Guido et al. | Short-term stimulation studies on neonatal pig pancreatic duct-derived cell monolayers | |
| Soria-Juan et al. | Generation of pancreatic islets from stem cells | |
| Rojas | Pluripotent stem cell-derived islet encapsulation in alginate beads via a scalable emulsion-based process | |
| Goli | SerpinB1 Effects on Human Pancreatic Ductal Cells |